{
    "2020-09-25": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Chesapeake Utilities to Join S&P SmallCap 600",
                "features": {
                    "keywords": [
                        "Chesapeake",
                        "Utilities",
                        "S&P",
                        "SmallCap",
                        "600"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "utilities"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "Dow Jones Finishes Week With Strong Gains; This Leaderboard Stock Is In Buy Range",
                "features": {
                    "keywords": [
                        "Dow",
                        "Jones",
                        "strong gains",
                        "buy range"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Johnson & Johnson stock rises Friday, still underperforms market",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "stock rises",
                        "underperforms"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "Analyst Report: Johnson & Johnson",
                "features": {
                    "keywords": [
                        "Analyst Report",
                        "Johnson & Johnson"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "Johnson & Johnson COVID-19 vaccine produces strong immune response in early trial",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "COVID-19",
                        "vaccine",
                        "strong immune response"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "There are four coronavirus vaccines in late-stage studies — here’s how they differ",
                "features": {
                    "keywords": [
                        "coronavirus",
                        "vaccines",
                        "late-stage studies"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "Why Covid-19 Vaccine Prices May Be Unexpectedly Low",
                "features": {
                    "keywords": [
                        "Covid-19",
                        "Vaccine Prices",
                        "Unexpectedly Low"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-09",
                "original_text": "Dow Jones Up 100 Points After Early Dive; Apple, Microsoft Lead Tech Stock Rally",
                "features": {
                    "keywords": [
                        "Dow Jones",
                        "Up 100 Points",
                        "Tech Stock Rally"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-10",
                "original_text": "J&J: most Phase 1/2a participants in COVID-19 vaccine developed neutralizing antibodies",
                "features": {
                    "keywords": [
                        "J&J",
                        "Phase 1/2a",
                        "COVID-19",
                        "neutralizing antibodies"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-11",
                "original_text": "Dow Jones Comes Back From Early Dive; Apple, Microsoft Lead Tech Stock Rally",
                "features": {
                    "keywords": [
                        "Dow Jones",
                        "Early Dive",
                        "Tech Stock Rally"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-12",
                "original_text": "U.S. nears 7M coronavirus cases, big pharmaceutical companies race for a vaccine",
                "features": {
                    "keywords": [
                        "U.S.",
                        "coronavirus cases",
                        "pharmaceutical companies",
                        "vaccine"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-13",
                "original_text": "J&J signs manufacturing deal with GRAM for potential COVID-19 vaccine",
                "features": {
                    "keywords": [
                        "J&J",
                        "manufacturing deal",
                        "GRAM",
                        "COVID-19 vaccine"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-14",
                "original_text": "Is JNJ Stock A Buy As Pharma Giant Starts Final-Phase Coronavirus Vaccine Trials?",
                "features": {
                    "keywords": [
                        "JNJ Stock",
                        "Buy",
                        "Final-Phase",
                        "Coronavirus Vaccine Trials"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-15",
                "original_text": "Another Covid-19 Vaccine Candidate Is in the Final Stage of Testing",
                "features": {
                    "keywords": [
                        "Covid-19",
                        "Vaccine Candidate",
                        "Final Stage"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-16",
                "original_text": "Novavax Is Starting a Phase 3 Trial of Its Covid-19 Vaccine. The Stock Is Jumping.",
                "features": {
                    "keywords": [
                        "Novavax",
                        "Phase 3 Trial",
                        "Covid-19 Vaccine",
                        "Stock Is Jumping"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-17",
                "original_text": "3 Dividend Aristocrats to Buy and Hold Forever",
                "features": {
                    "keywords": [
                        "Dividend Aristocrats",
                        "Buy and Hold Forever"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "dividends"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-18",
                "original_text": "Patient Investors Will Stick With Very Cheap Bristol-Myers Squibb Stock",
                "features": {
                    "keywords": [
                        "Patient Investors",
                        "Bristol-Myers Squibb",
                        "Cheap Stock"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}